Europe Human Leukocyte Antigen (HLA) Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product and service (Reagents & Consumables, Instruments, and Software & Services), Technology (Molecular Assay Technologies and Non-Molecular Assay Technologies), and End User (Independent Reference Laboratories, Hospitals and Transplant Centers, and Others)

Code: BMIRE00025755 | Pages: 166 | Industry: Biotechnology | Date: Sep 2022 | Type: Regional

The Europe human leukocyte antigen (HLA) testing market is expected to grow from US$ 188.49 million in 2022 to US$ 287.77 million by 2028; it is estimated to grow at a CAGR of 7.3% from 2022 to 2028.

 

The broadening scope of applications of HLA testing makes it mandatory before several medical procedures. The histocompatibility laboratory at TriCore Reference Laboratories provides HLA-related testing for transplantation, platelet donation/blood transfusion, forensic testing, parentage testing, disease association, pharmacogenomics, and transfusion medicine applications; among these, HLA testing is commonly used in disease-association testing. Specific HLA alleles are associated with high or low exposure to various diseases. HLA testing can also be used as a complementary method for diagnosing and assessing hereditary risks. The confirmation of the presence or absence of HLA factors associated with each disease or drug-induced adverse reactions can significantly impact therapeutics. Further, blood transfusion is one of the primary procedures that require HLA testing. Several chronic conditions, surgical procedures, and trauma cases require blood transfusion so that patients can survive without any side effects of low blood levels. Conditions including thalassemia, blood cancer, sickle cell anemia, anemia, and surgical and trauma cases lead to blood loss and require a blood transfusion. Thus, the increasing prevalence of chronic diseases magnifies the demand for blood transfusion, thereby propelling the growth of the HLA testing market.

 

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe human leukocyte antigen (HLA) testing market at a notable CAGR during the forecast period.

 

Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

 

Europe Human Leukocyte Antigen (HLA) Testing Market Segmentation  

The Europe human leukocyte antigen (HLA) testing market is segmented into product & services, technology, end user, and country. Based on product & services, the market is segmented into reagents & consumables, instruments, and software & services. In terms of technology, the Europe human leukocyte antigen (HLA) testing market is divided into molecular assay technologies and non-molecular assay technologies. The molecular assay technologies segment is sub segmented into PCR-based molecular assays, sequencing-based molecular assays, and others. Based on end user, the market is divided into independent reference laboratories, hospital and transplant centers, and others. Based on country, the Europe human leukocyte antigen (HLA) testing market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe.

 

Europe Human Leukocyte Antigen (HLA) Testing Market — Companies Mentioned

THERMO FISHER SCIENTIFIC INC.; CareDx; QIAGEN; Illumina, Inc.; Bio-Rad Laboratories, Inc.; F. HOFFMANN-LA ROCHE LTD.; Takara Bio Inc.; Luminex Corporation; Omixon Inc.; Protrans; and CeGaT GmbH are among the major companies operating in the Europe human leukocyte antigen (HLA) testing market.

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Human Leukocyte Antigen (HLA) Testing Market – By Product and Services

1.3.2        Europe Human Leukocyte Antigen (HLA) Testing Market – By Technology

1.3.3        Europe Human Leukocyte Antigen (HLA) Testing Market – By End User

1.3.4        Europe Human Leukocyte Antigen (HLA) Testing Market – By Country

2.           Europe Human Leukocyte Antigen (HLA) Testing Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Human Leukocyte Antigen (HLA) Testing Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Europe – PEST Analysis

4.3         Expert Opinion

5.           Europe Human Leukocyte Antigen (HLA) Testing Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Number of Plasma Donation and Organ Transplantation Procedures

5.1.2        Expanding Range of Applications of HLA Testing

5.2         Market Restraints

5.2.1        Errors in Accuracy

5.3         Market Opportunities

5.3.1        Rising Government Funding for Organ Donation

5.4         Future Trends

5.4.1        Technological Advancements in Field of Histocompatibility

5.5         Impact Analysis

6.           Europe Human Leukocyte Antigen (HLA) Testing Market –Analysis

6.1         Europe Human Leukocyte Antigen (HLA) Testing Market Revenue Forecast and Analysis

7.           Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 – by Product and Services

7.1         Overview

7.2         Europe Human Leukocyte Antigen (HLA) Testing Market Share, By Product and Services 2022 & 2028 (%)

7.3         Reagents and Consumables

7.3.1        Overview

7.3.2        Reagents and Consumables: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

7.4         Instruments

7.4.1        Overview

7.4.2        Instruments: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

7.5         Software and Services

7.5.1        Overview

7.5.2        Software and Services : Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

8.           Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by Technology

8.1         Overview

8.2         Europe Human Leukocyte Antigen (HLA) Testing Market, By Technology 2022 & 2028 (%)

8.3         Molecular Assay Technologies

8.3.1        Overview

8.3.2        Molecular Assay Technologies: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

8.3.3        PCR-Based Molecular Assays

8.3.3.1          Overview

8.3.3.2          PCR-Based Molecular Assays: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

8.3.4        Sequencing-Based Molecular Assays

8.3.4.1          Overview

8.3.4.2          Sequencing-Based Molecular Assays: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

8.3.5        Others

8.3.5.1          Overview

8.3.5.2          Others: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

8.4         Non-Molecular Assay Technologies

8.4.1        Overview

8.4.2        Non-Molecular Assay Technologies: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

9.           Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by End User

9.1         Overview

9.2         Europe Human Leukocyte Antigen (HLA) Testing Market, By End User 2022 & 2028 (%)

9.3         Independent Reference Laboratories

9.3.1        Overview

9.3.2        Independent Reference Laboratories: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

9.4         Hospital & Transplant Centers

9.4.1        Overview

9.4.2        Hospital & Transplant Centers: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

9.5         Others

9.5.1        Overview

9.5.2        Others: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

10.        Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028– by Country

10.1      Europe: Europe Human Leukocyte Antigen (HLA) Testing Market

10.1.1     Overview

10.1.2     Europe: Europe Human Leukocyte Antigen (HLA) Testing Market - Revenue and Forecast to 2028 (US$ Million)

10.1.3     Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.4     Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.4.1       Europe: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.5     Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.1.6     Europe: Europe Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)

10.1.6.1       Germany: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.1       Germany: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.2       Germany: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.6.1.3       Germany: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.1.3.1    Germany: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.1.4       Germany: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.1.6.2       France: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.1       France: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.2       France: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.6.2.3       France: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.2.3.1    France: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.2.4       France: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.1.6.3       UK: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.1       UK: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.2       UK: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.6.3.3       UK: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.3.3.1    UK: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.3.4       UK: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.1.6.4       Italy: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.4.1       Italy: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.4.2       Italy: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.6.4.3       Italy: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.4.3.1    Italy: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.4.4       Italy: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.1.6.5       Spain: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.5.1       Spain: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.5.2       Spain: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.6.5.3       Spain: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.5.3.1    Spain: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.5.4       Spain: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

10.1.6.6       Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.6.1       Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.6.2       Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

10.1.6.6.3       Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.6.3.1    Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

10.1.6.6.4       Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

11.        Europe Human Leukocyte Antigen (HLA) Testing Market – Industry Landscape

11.1      Overview

11.2      Growth Strategies in the Europe Human Leukocyte Antigen (HLA) Testing Market (%)

11.3      Organic Developments

11.3.1     Overview

11.4      Inorganic Developments

11.4.1     Overview

12.        Company Profiles

12.1      THERMO FISHER SCIENTIFIC INC.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      CareDx

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      QIAGEN

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Illumina, Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Bio-Rad Laboratories, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      F. HOFFMANN-LA ROCHE LTD.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Takara Bio Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Luminex Corporation

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Omixon Inc.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Protrans

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

12.11   CeGaT GmbH

12.11.1  Key Facts

12.11.2  Business Description

12.11.3  Products and Services

12.11.4  Financial Overview

12.11.5  SWOT Analysis

12.11.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 2.             Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 3.             Europe: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 4.             Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 5.             Germany: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 6.             Germany: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 7.             Germany: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 8.             Germany: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 9.             France: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 10.          France: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 11.          France: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 12.          France: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 13.          UK: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 14.          UK: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 15.          UK: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 16.          UK: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 17.          Italy: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 18.          Italy: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 19.          Italy: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 20.          Italy: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 21.          Spain: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 22.          Spain: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 23.          Spain: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 24.          Spain: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 25.          Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Product and Services (US$ Million)

Table 26.          Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By Technology (US$ Million)

Table 27.          Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market for Molecular Assay Technology Revenue and Forecast To 2028, By Technology (US$ Million)

Table 28.          Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028, By End User (US$ Million)

Table 29.          Organic Developments in the Europe Human Leukocyte Antigen (HLA) Testing Market

Table 30.          Inorganic Developments in the Europe Human Leukocyte Antigen (HLA) Testing Market

Table 31.          Glossary of Terms, Europe Human Leukocyte Antigen (HLA) Testing Market

 

 

LIST OF FIGURES

Figure 1.           Europe Human Leukocyte Antigen (HLA) Testing Market Segmentation

Figure 2.           Europe Human Leukocyte Antigen (HLA) Testing Market Overview

Figure 3.           Reagents And Consumables Held Largest Share of Product Segment in Europe Human Leukocyte Antigen (HLA) Testing Market

Figure 4.           Germany is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Europe: PEST Analysis

Figure 6.           Experts’ Opinion

Figure 7.           HLA Testing Market: Impact Analysis of Drivers and Restraints

Figure 8.           Europe Human Leukocyte Antigen (HLA) Testing Market– Revenue Forecast and Analysis – 2020- 2028

Figure 9.           Europe Human Leukocyte Antigen (HLA) Testing Market Share, By Product and Services 2022 & 2028 (%)

Figure 10.        Reagents and Consumables: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

Figure 11.        Instruments: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

Figure 12.        Software and Services : Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast To 2028 (US$ Million)

Figure 13.        Europe Human Leukocyte Antigen (HLA) Testing Market, By Technology 2022 & 2028 (%)

Figure 14.        Molecular Assay Technologies: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        PCR-Based Molecular Assays: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Sequencing-Based Molecular Assays: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Others: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Non-Molecular Assay Technologies: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Europe Human Leukocyte Antigen (HLA) Testing Market Share, By End User 2022 & 2028 (%)

Figure 20.        Independent Reference Laboratories: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Hospital & Transplant Centers: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Others: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Europe: Europe Human Leukocyte Antigen (HLA) Testing Market Revenue Overview, by Key Country – Revenue (2022) (US$ Million)

Figure 24.        Europe Europe Human Leukocyte Antigen (HLA) Testing Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Europe: Europe Human Leukocyte Antigen (HLA) Testing Market, by Country, 2022 & 2028 (%)

Figure 26.        Germany: Human Leukocyte Antigen (HLA) Testing Products Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        France: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        UK: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Italy: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Spain: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Rest of Europe: Europe Human Leukocyte Antigen (HLA) Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Growth Strategies in the Europe Human Leukocyte Antigen (HLA) Testing Market (%)

  1.  THERMO FISHER SCIENTIFIC INC.                            
  2. CareDx                                                                                
  3. QIAGEN                                                                                              
  4. Illumina, Inc.                                                                     
  5. Bio-Rad Laboratories, Inc.                                           
  6. F. HOFFMANN-LA ROCHE LTD.                                  
  7. Takara Bio Inc.                                                                  
  8. Luminex Corporation                                                    
  9. Omixon Inc.                                                                       
  10. Protrans                                                                              
  11. CeGaT GmbH                                                                  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000